4//SEC Filing
Valeant Pharmaceuticals International, Inc. 4
Accession 0000885590-15-000052
$BHCCIK 0000885590operating
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 4:20 PM ET
Size
6.0 KB
Accession
0000885590-15-000052
Insider Transaction Report
Form 4
Stolz Brian M.
EVP, Administration and CHCO
Transactions
- Tax Payment
Common Stock, no par value
2015-06-22+2,292→ 125,280 total
Footnotes (3)
- [F1]This number represents common shares ("Common Shares") of Valeant Pharmaceuticals, Inc. ("Valeant") withheld to satisfy the tax withholding obligations due upon vesting of performance-based RSUs.
- [F2]This number includes the maximum number of Common Shares that may be delivered in settlement of performance-based Restricted Share Units ("PSUs") that were previously reported on Form 4 in Table II. See note (3).
- [F3]The initial grant of PSUs was reported to vest based on total shareholder return ("TSR") between a price of $51.76 starting on August 10, 2011 and the average stock price for the 20 trading days starting on each measurement dates: 25% on May 10, 2014, 50% August 10, 2014 and 25% on November 10, 2014 (or 25% on May 10, 2015, 50% on August 10, 2015 and 25% on November 10, 2015, if applicable). Unit vesting is contingent on TSR performance between 15% and 45% into between one and three shares of common stock, respectively, with early vesting possible at higher TSR levels. These performance-based RSUs remain unvested for up to 29,044 Common Shares.
Documents
Issuer
Valeant Pharmaceuticals International, Inc.
CIK 0000885590
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0000885590
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 4:20 PM ET
- Size
- 6.0 KB